Dr Reddys Laboratories (RDY) Cash from Investing Activities (2009)

Dr Reddys Laboratories (RDY) posted quarterly Cash from Investing Activities of -$48.0 million for Q4 2009, down 242.86% on a QoQ basis from -$14.0 million in Q3 2009.

Dr Reddys Laboratories (RDY) Cash from Investing Activities (2009) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Cash from Investing Activities for 1 consecutive years, with -$48.0 million the latest figure, recorded in Q4 2009.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to -$48.0 million in Q4 2009, while the trailing twelve-month figure through Dec 2009 was -$69.5 million (changed N/A YoY) and the FY2026 annual result came in at -$700.0 million, down 2.64% from the prior year.
  • Cash from Investing Activities eased to -$48.0 million in Q4 2009 per RDY's latest filing, from -$14.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for RDY reached as high as -$12.0 million in Q2 2009 and fell as low as -$48.0 million in Q4 2009.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.95 Bn 88.09 Bn - -
2 Teva Pharmaceutical Industries 35.88 Bn 32.14 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.64 Bn 30.70 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.04 Bn 20.88 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.37 Bn 18.57 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.45 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn -60.00 Mn
10 Dr Reddys Laboratories 9.86 Bn 9.69 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2009 -48.00 Mn
Dec 31, 2009 -48.00 Mn
Sep 30, 2009 -14.00 Mn
Sep 30, 2009 -14.00 Mn
Jun 30, 2009 -12.00 Mn
Jun 30, 2009 -12.00 Mn